The Europe non-alcoholic steatopatitis market is expected to reach US$ 6,765.21 million by 2028 from US$ 496.83 million in 2021. The market is estimated to grow at a CAGR of 45.2% from 2021 to 2028.
Raising Awareness of Europe non-alcoholic steatopatitis market
Non-Alcoholic Steatohepatitis (NASH) remains a significantly under-recognized condition, yet its prevalence affects an...
Σχετικά
Terms And Conditions
English
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
